Search Results - "Ahluwalia, M."

Stable and Discriminatory Radiomic Features from the Tumor and Its Habitat Associated with Progression-Free Survival in Glioblastoma: A Multi-Institutional Study by Verma, R, Hill, V B, Statsevych, V, Bera, K, Correa, R, Leo, P, Ahluwalia, M, Madabhushi, A, Tiwari, P

“…Glioblastoma is an aggressive brain tumor, with no validated prognostic biomarkers for survival before surgical resection. Although recent approaches have…”
Get full text

Phase III METIS study: Tumor treating fields (150 kHz) and radiosurgery for supra- and/or infratentorial brain metastases (1-10) from non-small cell lung cancer (NSCLC) by Mehta, M., Gondi, V., Ahluwalia, M., Brown, P.

Get full text

Multi-institutional competing risks analysis of distant brain failure and salvage patterns after upfront radiosurgery without whole brain radiotherapy for brain metastasis by McTyre, E., Ayala-Peacock, D., Contessa, J., Corso, C., Chiang, V., Chung, C., Fiveash, J., Ahluwalia, M., Kotecha, R., Chao, S., Attia, A., Henson, A., Hepel, J., Braunstein, S., Chan, M.

“…In this study, we use a competing risks analysis to assess factors predictive of early-salvage whole brain radiotherapy (WBRT) and early death after upfront…”
Get full text

Integrating imaging modalities for diagnosing cardiac amyloidosis by Ahluwalia, M., Reyentovich, A., Donnino, R., Phillips, L.M.

Get full text

Malignant Transformation of Adult Low Grade Glioma: Risk Factors and Outcomes in the Molecular Era by Tom, M.C., Park, D.Y.J., Wei, W., Leyrer, C.M., Yang, K., Jia, X., Varra, V., Yu, J.S., Chao, S.T., Suh, J.H., Vogelbaum, M.A., Barnett, G.H., Stevens, G., Peereboom, D., Ahluwalia, M., Murphy, E.S.

Get full text

Treatment Outcome of Adult Primary Spinal Cord Lymphoma: A Population-Based Study by Yang, K, Kim, L.J.Y, Suh, J.H, Murphy, E.S, Peereboom, D, Ahluwalia, M, Chao, S.T

Get full text

The gene expression signature of anagrelide provides an insight into its mechanism of action and uncovers new regulators of megakaryopoiesis by Ahluwalia, M., Butcher, L., Donovan, H., Killick‐Cole, C., Jones, P. M., Erusalimsky, J. D.

“…Summary Background Anagrelide is a cytoreductive agent used to lower platelet counts in essential thrombocythemia. Although the drug has been known to…”
Get full text

Health Care Expenditures Associated With the Management of Multiple Brain Metastases by Miller, J.A, Kotecha, R, Mohammadi, A.M, Murphy, E.S, Suh, J.H, Barnett, G.H, Vogelbaum, M.A, Angelov, L, Ahluwalia, M, Chao, S.T

Get full text

Spine Stereotactic Radiosurgery With Concurrent Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma by Miller, J.A, Balagamwala, E.H, Angelov, L, Suh, J.H, Rini, B, Garcia, J, Ahluwalia, M, Chao, S.T

Get full text

Quality of Life following Stereotactic Radiosurgery for Single and Multiple Brain Metastases by Miller, J.A, Kotecha, R, Barnett, G.H, Suh, J.H, Angelov, L, Murphy, E.S, Vogelbaum, M.A, Mohammadi, A.M, Ahluwalia, M, Chao, S.T

Get full text

The Economic Implication of Upfront Whole-Brain Radiation Therapy for Patients With Limited Brain Metastasis by Miller, J.A, Kotecha, R, Mohammadi, A.M, Murphy, E.S, Suh, J.H, Barnett, G.H, Vogelbaum, M.A, Angelov, L, Ahluwalia, M, Chao, S.T

Get full text

Brain metastases: A new Graded Prognostic Assessment (GPA) index by Ahluwalia, M, Dahiya, S, Elson, P

Get full text

Impact of BRAF Mutation on Outcome Following Stereotactic Radiosurgery in Melanoma Brain Metastases by Kotecha, R, Venur, V. Alva, Murphy, E.S, Yu, J.S, Chao, S.T, Suh, J.H, Elson, P, Angelov, L, Barnett, G, Ahluwalia, M

Get full text

Pulsed Reduced Dose Rate Reirradiation for Recurrent Primary Central Nervous System Tumors by Murphy, E.S, Rogacki, K, Suh, J.H, Ahluwalia, M, Reddy, C.A, Yu, J.S, Qi, P, Stevens, G.H.J, Peereboom, D, Chao, S.T

Get full text

Prognostic Factors for Adult Low Grade Glioma Patients 40 Years of Age and Younger by Murphy, E.S, Leyrer, C.M, Vogelbaum, M.A, Elson, P, Chao, S.T, Suh, J.H, Stevens, G.H.J, Peereboom, D, Barnett, G, Ahluwalia, M

Get full text

Patients With Brain Metastases Treated Across Two Decades: Times Change But Does Survival Stay the Same? by Patel, K, Kotecha, R, Ahluwalia, M, Suh, J.H, Reddy, C.A, Barnett, G, Vogelbaum, M.A, Angelov, L, Murphy, E.S, Chao, S.T

Get full text

In Silico Mapping of Complex Disease-Related Traits in Mice by Grupe, Andrew, Germer, Soren, Usuka, Jonathan, Aud, Dee, Belknap, John K., Klein, Robert F., Ahluwalia, Mandeep K., Higuchi, Russell, Peltz, Gary

“…Experimental murine genetic models of complex human disease show great potential for understanding human disease pathogenesis. To reduce the time required for…”
Get full text

Anagrelide represses GATA‐1 and FOG‐1 expression without interfering with thrombopoietin receptor signal transduction by AHLUWALIA, M., DONOVAN, H., SINGH, N., BUTCHER, L., ERUSALIMSKY, J. D.

“…Background: Anagrelide is a selective inhibitor of megakaryocytopoiesis used to treat thrombocytosis in patients with chronic myeloproliferative disorders. The…”
Get full text

Multi-Institutional Competing Risks Analysis Predicting Distant Brain Failure and Salvage Patterns After Upfront Radiosurgery Without Whole-Brain Radiation Therapy for Brain Metastasis by McTyre, E, Ayala-Peacock, D.N, Contessa, J.N, Chung, C, Fiveash, J.B, Ahluwalia, M, Kotecha, R, Chao, S.T, Attia, A, Hepel, J.T, Braunstein, S.E, Chan, M.D

Get full text

Institutional Experience of High-Risk, Low-Grade Glioma in the Temozolomide Era by Leyrer, C.M, Murphy, E.S, Chao, S.T, Vogelbaum, M.A, Stevens, G.H.J, Peereboom, D, Barnett, G.H, Mohammadi, A.M, Yu, J.S, Suh, J.H, Ahluwalia, M

Get full text